Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123136434 | 12313643 | 4 | F | 20140416 | 20160715 | 20160428 | 20160721 | EXP | CA-JNJFOC-20160425079 | JANSSEN | 55.90 | YR | A | F | Y | 49.70000 | KG | 20160721 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123136434 | 12313643 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | FKM95012;FLM04015;GBM13011 +MORE | 0 | 300 | MG | LYOPHILIZED POWDER | ||||||
| 123136434 | 12313643 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | FKM95012;FLM04015;GBM13011 +MORE | 0 | 300 | MG | LYOPHILIZED POWDER | ||||||
| 123136434 | 12313643 | 3 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | FKM95012;FLM04015;GBM13011 +MORE | 103772 | 300 | MG | LYOPHILIZED POWDER | ||||||
| 123136434 | 12313643 | 4 | C | CELEBREX | CELECOXIB | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123136434 | 12313643 | 5 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123136434 | 12313643 | 6 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123136434 | 12313643 | 7 | C | VITAMIN C | ASCORBIC ACID | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123136434 | 12313643 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123136434 | 12313643 | 9 | C | CENTRUM | VITAMINS | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123136434 | 12313643 | 10 | C | LOMOTIL | ATROPINE SULFATEDIPHENOXYLATE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123136434 | 12313643 | 11 | C | BUSCOPAN | BUTYLSCOPOLAMINE BROMIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123136434 | 12313643 | 12 | C | IRON | IRON | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123136434 | 12313643 | 13 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123136434 | 12313643 | 1 | Crohn's disease |
| 123136434 | 12313643 | 2 | Crohn's disease |
| 123136434 | 12313643 | 3 | Crohn's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123136434 | 12313643 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123136434 | 12313643 | Abdominal distension | |
| 123136434 | 12313643 | Abdominal pain | |
| 123136434 | 12313643 | Back pain | |
| 123136434 | 12313643 | Depression | |
| 123136434 | 12313643 | Diarrhoea | |
| 123136434 | 12313643 | Facial pain | |
| 123136434 | 12313643 | Fatigue | |
| 123136434 | 12313643 | General physical health deterioration | |
| 123136434 | 12313643 | Intestinal stenosis | |
| 123136434 | 12313643 | Off label use | |
| 123136434 | 12313643 | Pain in extremity | |
| 123136434 | 12313643 | Paraesthesia | |
| 123136434 | 12313643 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123136434 | 12313643 | 1 | 20160621 | 0 | ||
| 123136434 | 12313643 | 2 | 20160715 | 0 | ||
| 123136434 | 12313643 | 3 | 20140416 | 0 | ||
| 123136434 | 12313643 | 5 | 20160507 | 0 |